ADVERTISEMENT

ERS 2022 — Antibiotics a ‘no-no’ in early-life severe respiratory syncytial virus bronchiolitis

Shrabasti Bhattacharya   |   Conference Report   |   09 September 2022
ADVERTISEMENT

Takeaway

  • In infants with early-life severe respiratory syncytial virus (RSV) bronchiolitis, a 14-day treatment with azithromycin did not lower the risk for recurrent wheezing over the following 2-4 years.
  • The risk for recurrent wheezing was higher with azithromycin versus placebo when the participants did not receive any other antibiotic.
  • The use...

          

September Challenge

Ends in 7d 4h
left
right

Topic Challenges

left
right